Shares

41 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$83.49 - $94.64 $112,210 - $127,196
-1,344 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $53.8 Million - $67.4 Million
-744,278 Reduced 99.82%
1,344 $103,000
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $593,510 - $652,712
8,280 Added 1.12%
745,622 $56 Million
Q2 2021

Aug 06, 2021

SELL
$70.31 - $77.77 $705,912 - $780,810
-10,040 Reduced 1.34%
737,342 $57.3 Million
Q1 2021

May 07, 2021

SELL
$68.86 - $81.11 $158,378 - $186,553
-2,300 Reduced 0.31%
747,382 $71.9 Million
Q4 2020

Feb 11, 2021

BUY
$71.77 - $79.65 $7.51 Million - $8.34 Million
104,700 Added 16.23%
749,682 $72.9 Million
Q3 2020

Nov 12, 2020

SELL
$73.18 - $82.95 $6.83 Million - $7.74 Million
-93,311 Reduced 12.64%
644,982 $65.9 Million
Q2 2020

Aug 11, 2020

BUY
$70.42 - $80.13 $2.51 Million - $2.86 Million
35,709 Added 5.08%
738,293 $69.2 Million
Q1 2020

May 28, 2020

SELL
$63.36 - $87.82 $4.14 Million - $5.74 Million
-65,400 Reduced 8.52%
702,584 $66.5 Million
Q4 2019

Jan 30, 2020

BUY
$77.58 - $87.54 $11 Million - $12.4 Million
141,200 Added 22.53%
767,984 $84.2 Million
Q3 2019

Nov 13, 2019

SELL
$76.08 - $82.93 $157 Million - $171 Million
-2,062,988 Reduced 76.7%
626,784 $64.2 Million
Q2 2019

Jul 23, 2019

BUY
$69.84 - $81.59 $4.54 Million - $5.3 Million
65,000 Added 2.48%
2,689,772 $256 Million
Q1 2019

May 01, 2019

BUY
$69.58 - $79.36 $4.51 Million - $5.14 Million
64,800 Added 2.53%
2,624,772 $248 Million
Q4 2018

Jan 29, 2019

SELL
$65.24 - $75.71 $45.6 Million - $52.9 Million
-698,900 Reduced 21.45%
2,559,972 $222 Million
Q3 2018

Oct 29, 2018

SELL
$57.69 - $67.84 $18.3 Million - $21.6 Million
-317,684 Reduced 8.88%
3,258,872 $261 Million
Q2 2018

Jul 24, 2018

BUY
$50.83 - $59.72 $8.02 Million - $9.42 Million
157,800 Added 4.62%
3,576,556 $241 Million
Q1 2018

May 14, 2018

SELL
$50.96 - $59.23 $8.54 Million - $9.92 Million
-167,500 Reduced 4.67%
3,418,756 $205 Million
Q4 2017

Jan 31, 2018

SELL
$51.62 - $61.64 $317 Million - $378 Million
-6,140,191 Reduced 63.13%
3,586,256 $220 Million
Q3 2017

Oct 19, 2017

SELL
$58.67 - $63.13 $136 Million - $147 Million
-2,326,148 Reduced 19.3%
9,726,447 $672 Million
Q2 2017

May 25, 2022

BUY
N/A
2,326,148 Added 23.92%
12,052,595 $835 Million
Q2 2017

May 24, 2022

SELL
N/A
-2,326,148 Reduced 19.3%
9,726,447 $0
Q2 2017

May 14, 2018

BUY
N/A
458,950 Added 3.96%
12,052,595 $835 Million
Q1 2017

Sep 07, 2022

BUY
N/A
1,867,198 Added 19.2%
11,593,645 $752 Million
Q1 2017

May 24, 2022

SELL
N/A
-1,867,198 Reduced 16.11%
9,726,447 $0
Q1 2017

May 14, 2018

BUY
N/A
365,276 Added 3.25%
11,593,645 $752 Million
Q4 2016

May 14, 2018

BUY
N/A
172,426 Added 1.56%
11,228,369 $680 Million
Q3 2016

May 25, 2022

BUY
N/A
74,900 Added 0.68%
11,055,943 $702 Million
Q2 2016

May 25, 2022

BUY
N/A
22,797 Added 0.21%
10,981,043 $645 Million
Q1 2016

Sep 07, 2022

BUY
N/A
1,365,146 Added 14.23%
10,958,246 $580 Million
Q4 2015

Sep 07, 2022

BUY
N/A
345,000 Added 3.73%
9,593,100 $507 Million
Q3 2015

Sep 07, 2022

BUY
N/A
286,300 Added 3.19%
9,248,100 $457 Million
Q2 2015

Sep 07, 2022

BUY
N/A
2,162,773 Added 31.81%
8,961,800 $510 Million
Q4 2012

Sep 07, 2022

BUY
N/A
618,400 Added 10.01%
6,799,027 $278 Million
Q3 2012

Sep 07, 2022

BUY
N/A
297,800 Added 5.06%
6,180,627 $279 Million
Q2 2012

Sep 07, 2022

BUY
N/A
263,100 Added 4.68%
5,882,827 $246 Million
Q1 2012

Sep 07, 2022

BUY
N/A
694,400 Added 14.1%
5,619,727 $216 Million
Q4 2011

Sep 07, 2022

BUY
N/A
493,427 Added 11.13%
4,925,327 $186 Million
Q3 2011

Sep 07, 2022

BUY
N/A
98,900 Added 2.28%
4,431,900 $145 Million
Q2 2011

Sep 07, 2022

BUY
N/A
91,900 Added 2.17%
4,333,000 $153 Million
Q1 2011

Sep 07, 2022

BUY
N/A
2,000 Added 0.05%
4,241,100 $140 Million
Q4 2010

Sep 07, 2022

BUY
N/A
4,239,100
4,239,100 $153 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $250B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Sanders Capital, LLC Portfolio

Follow Sanders Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sanders Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sanders Capital, LLC with notifications on news.